128 related articles for article (PubMed ID: 24628241)
1. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine.
Bonilla X; Dakir el-H; Mollinedo F; Gajate C
Oncotarget; 2015 Jun; 6(16):14596-613. PubMed ID: 25999349
[TBL] [Abstract][Full Text] [Related]
3. Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.
Carrasco MP; Jiménez-López JM; Ríos-Marco P; Segovia JL; Marco C
Br J Pharmacol; 2010 May; 160(2):355-66. PubMed ID: 20423345
[TBL] [Abstract][Full Text] [Related]
4. Suppression of metastatic organ colonization and antiangiogenic activity of the orally bioavailable lipid raft-targeted alkylphospholipid edelfosine.
Alonso-Pérez V; Hernández V; Calzado MA; Vicente-Blázquez A; Gajate C; Soler-Torronteras R; DeCicco-Skinner K; Sierra A; Mollinedo F
Biomed Pharmacother; 2024 Feb; 171():116149. PubMed ID: 38266621
[TBL] [Abstract][Full Text] [Related]
5. Alteration of plasma membrane organization by an anticancer lysophosphatidylcholine analogue induces intracellular acidification and internalization of plasma membrane transporters in yeast.
Czyz O; Bitew T; Cuesta-Marbán A; McMaster CR; Mollinedo F; Zaremberg V
J Biol Chem; 2013 Mar; 288(12):8419-8432. PubMed ID: 23344949
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of alkylphospholipid edelfosine in prostate cancer models and endoplasmic reticulum targeting.
Dakir EH; Gajate C; Mollinedo F
Biomed Pharmacother; 2023 Nov; 167():115436. PubMed ID: 37683591
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin Treatment Inducing Apoptosis in Human Pancreatic Cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria.
Gyoten M; Luo Y; Fujiwara-Tani R; Mori S; Ogata R; Kishi S; Kuniyasu H
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069135
[TBL] [Abstract][Full Text] [Related]
8. Lipid raft: A floating island of death or survival.
George KS; Wu S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):311-9. PubMed ID: 22289360
[TBL] [Abstract][Full Text] [Related]
9. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection.
Varghese E; Samuel SM; Sadiq Z; Kubatka P; Liskova A; Benacka J; Pazinka P; Kruzliak P; Büsselberg D
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226817
[TBL] [Abstract][Full Text] [Related]
10. Rafting Down the Metastatic Cascade: The Role of Lipid Rafts in Cancer Metastasis, Cell Death, and Clinical Outcomes.
Greenlee JD; Subramanian T; Liu K; King MR
Cancer Res; 2021 Jan; 81(1):5-17. PubMed ID: 32999001
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic Assemblies Disrupt the Membrane and Target Endoplasmic Reticulum for Selective Cancer Cell Death.
Feng Z; Wang H; Wang S; Zhang Q; Zhang X; Rodal AA; Xu B
J Am Chem Soc; 2018 Aug; 140(30):9566-9573. PubMed ID: 29995402
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
Zielonka J; Joseph J; Sikora A; Hardy M; Ouari O; Vasquez-Vivar J; Cheng G; Lopez M; Kalyanaraman B
Chem Rev; 2017 Aug; 117(15):10043-10120. PubMed ID: 28654243
[TBL] [Abstract][Full Text] [Related]
13. Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum.
Girigoswami K; Pallavi P; Girigoswami A
Drug Deliv; 2023 Dec; 30(1):2284684. PubMed ID: 37990530
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic Modulation of Endoplasmic Reticulum and Mitochondria Network Boosted Cancer Immunotherapy.
Wang X; Qian J; Yang Z; Song Y; Pan W; Ye Y; Qin X; Yan X; Huang X; Wang X; Gao M; Zhang Y
Adv Mater; 2024 Jan; 36(4):e2310964. PubMed ID: 37985146
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid antitumor agents.
Houlihan WJ; Lohmeyer M; Workman P; Cheon SH
Med Res Rev; 1995 May; 15(3):157-223. PubMed ID: 7658750
[No Abstract] [Full Text] [Related]
16. Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies.
Bernardes N; Fialho AM
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518103
[TBL] [Abstract][Full Text] [Related]
17. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
18. Rafting through traffic: Membrane domains in cellular logistics.
Diaz-Rohrer B; Levental KR; Levental I
Biochim Biophys Acta; 2014 Dec; 1838(12):3003-3013. PubMed ID: 25130318
[TBL] [Abstract][Full Text] [Related]
19. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 acts as a switch between necrotic and apoptotic cell death in ether phospholipid edelfosine-treated glioblastoma cells.
Melo-Lima S; Lopes MC; Mollinedo F
Pharmacol Res; 2015; 95-96():2-11. PubMed ID: 25749008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
